Son et al. [24] evaluated the prognostic significance of fibrinogen and inflammation-based scores, such as albumin, C-reactive protein, and neutrophil, lymphocyte, and PLT counts, as markers of the inflammatory response in colon cancer. The gene discussed is CRP; the disease is malignant colon neoplasm.